Spero Therapeutics, Inc. (SPRO:NASDAQ) closed at $1.02 on November 5, 2026, down 4.67% on the day. The stock trades 66.9% below its 52-week high of $3.08 and 6.1% above its 52-week low of $0.961. Over the past year, it lost 57.3%. Spero Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 5, 2025, SPRO closed higher on 108 days (43%). Its best day was September 22, 2026 (+19.30%) and its worst was June 17, 2026 (-23.83%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.
SmartPros Ltd. provides learning and educational solutions for accounting/finance, legal, engineering, securities, and insurance markets. It offers accounting and finance libraries; executive enterprise institute, a series of live seminars in the corporate and public accountant marketplace; SmartPros Advantage, a skills-based learning library; and Financial Management Network, a library of programs dealing with current topics. The company also provides CPA Report (CPAR), a library of programs covering topics in public accounting; and CPAR Government and Not-for-Profit, a library of designed for accounting professionals. Its engineering library includes FE Exam Review, a preparatory course for the basic entry-level licensing exam; PE Civil Exam review, a course for civil engineers; and a series of self-study PE Civil Exam preparation courses that cover the civil, mechanical, electrical, and chemical disciplines. In addition, the company offers engineering and management courses for professional development hours; project management for engineers; construction project management; and supply chain and certified in production and inventory management certification courses. Further, it...
Find more stocks like SPRO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.